Steven J. Skates

Harvard University — United States

Medicine · Health Sciences

69h-index21.5kcitations400works0.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(138), Immunotherapy and Immune Responses(125), vaccines and immunoinformatics approaches(113), Viral-associated cancers and disorders(95), Endometrial and Cervical Cancer Treatments(37)

Publications400 total

Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline
CA A Cancer Journal for Clinicians·2025· 2 citedOpen Access
Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samples
Gynecologic Oncology·2025· 1 citedOpen Access
Abstract A032: PTEN protein and lipid phosphatase deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer
Molecular Cancer Therapeutics·2025
Advancing Precision Oncology Through Modeling of Longitudinal and Multimodal Data
IEEE Reviews in Biomedical Engineering·2025· 3 citedOpen Access
Abstract LB152: Protocol for clinical validation of an ovarian cancer screening test using blinded retrospective evaluation of prospectively collected samples from a screening trial
Cancer Research·2025
Multicancer early detection testing: Guidance for primary care discussions with patients
Cancer·2025· 11 citedOpen Access
Combination Diagnostics: Adding Blood-Based ctDNA Screening to Low-Dose CT Imaging for Early Detection of Lung Cancer
Cancer Discovery·2024· 1 cited
B-308 Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women
Clinical Chemistry·2024Open Access
Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test
Journal of Molecular Diagnostics·2024· 13 citedOpen Access
Supplementary Figure 3 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 22 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Tables S1-S12 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 24 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 2 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 27 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 29 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 2 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 9 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 13 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
Supplementary Figure 25 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
2024Open Access
page 1 of 20Next →

Frequent Co-authors

Ian Jacobs(15), Robert C. Bast(13), Usha Menon(12), Karen H. Lu(9), Robert Woolas(8), Henry Rodriguez(7), Steven A. Carr(7), Naveena Singh(7), D.R. Mani(6), Christopher R. Kinsinger(6), Mehdi Mesri(6), Amanda G. Paulovich(6), Andy Ryan(6), Matthew Burnell(6), Anne Dawnay(6), David Oram(6), David F. Ransohoff(6), Richard G. Moore(6), Nora Horick(6), Michael A. Gillette(5)